Fig. 2: Univariate and multivariate survival analysis.

Forest plots showing hazard ratios for DFS (a) and OS (b) estimated by univariate and multivariate Cox proportional hazards regression outcome analyses, incorporating patient-, disease-, and treatment-specific characteristics. P-values were calculated using the Walden test. ECOG Eastern Cooperative Oncology Group Score, HCT hematopoietic cell transplantation, CMV cytomegalovirus, AML acute myeloid leukemia, sAML secondary acute myeloid leukemia, IM intermediate, fav favorable, n.a. not assessed, M(M)UD (mis)matched unrelated donor, MMRD mismatched related donor, MRD matched related donor, PB peripheral blood, BM bone marrow, Dg diagnosis, RTC reduced toxicity conditioning, MAC myeloablative conditioning, ATG anti-T lymphocyte globulin, Campath, Alemtuzumab.